Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 1-year average of -44.26%, near the high end of its 1-year range (-221.28%–0.00%).
100.00% above its 12-month average of -44.26%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -221.28%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
-44.26%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 558 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Ensysce Biosciences, Inc.
Market Cap
$6.57M
Operating Margin
0.00%
TTM Avg
-44.26%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.57M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.80M
Operating Margin
-9312.55%
TTM Avg
-10684.89%
3Y Avg
-9259.36%
5Y Avg
-8523.06%
Market Cap
$6.21M
Operating Margin
-119.54%
TTM Avg
-108.09%
3Y Avg
-117.27%
5Y Avg
-99.55%
Market Cap
$6.82M
Operating Margin
-450.07%
TTM Avg
-699.99%
3Y Avg
-986.00%
5Y Avg
-5433.17%
Market Cap
$6.28M
Operating Margin
-763.90%
TTM Avg
-929.35%
3Y Avg
-1043.46%
5Y Avg
-924.75%
Market Cap
$6.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-71.62%
Market Cap
$5.98M
Operating Margin
-43737.46%
TTM Avg
-33857.66%
3Y Avg
-147235.02%
5Y Avg
-109633.70%
Market Cap
$7.13M
Operating Margin
-5025.53%
TTM Avg
-3024.64%
3Y Avg
-1688.76%
5Y Avg
-1108.68%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ensysce Biosciences, Inc. (ENSC) | $6.57M | 0.00% | -44.26% | 0.00% | 0.00% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.57M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aclarion, Inc. (ACON)vs › | $6.80M | -9312.55% | -10684.89% | -9259.36% | -8523.06% |
| Biomerica, Inc. (BMRA)vs › | $6.21M | -119.54% | -108.09% | -117.27% | -99.55% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.82M | -450.07% | -699.99% | -986.00% | -5433.17% |
| Femasys Inc. (FEMY)vs › | $6.28M | -763.90% | -929.35% | -1043.46% | -924.75% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.06M | 0.00% | 0.00% | 0.00% | -71.62% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.98M | -43737.46% | -33857.66% | -147235.02% | -109633.70% |
| Co-Diagnostics, Inc. (CODX)vs › | $7.13M | -5025.53% | -3024.64% | -1688.76% | -1108.68% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.17M | 0.00% | 0.00% | -19.45% | -19.45% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -221.28% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | -29.48% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
